EDAP EDAP TMS S.A.

3.96
-0.14  -3%
Previous Close 4.1
Open 4.06
Price To Book 3.74
Market Cap 114,831,549
Shares 28,997,866
Volume 184,311
Short Ratio
Av. Daily Volume 146,928
Stock charts supplied by TradingView

NewsSee all news

  1. EDAP Issues Letter to Shareholders

    Recaps significant progress made in 2019 and previews expectations for accelerating global growth in 2020 LYON, France, January 9, 2020 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in

  2. EDAP Announces Publication of Focal One® Endometriosis Study in the Journal Ultrasound in Obstetrics & Gynecology

    Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis LYON, France, December 19, 2019 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced

  3. EDAP Announces First Focal One® HIFU treatments at Farrer Park Hospital in Singapore

    Farrer Park Hospital becomes the first hospital in Southeast Asia to implement Focal One®EDAP poised to expand HIFU in Southeast Asia LYON, France, November 26, 2019 -- EDAP TMS SA (NASDAQ:EDAP) ("the

  4. EDAP Reports 2019 Third Quarter and Nine Months Results

    67.8% growth in  HIFU revenue through the nine month period ended September 30 over the comparable period in 201848.2% Gross margin for the nine month period ended September 30 compared to 42.3% for the comparable period

  5. EDAP to Introduce New Endo-UP® Endourology Platform During the 2019 World Congress of Endourology

    New Endo-UP® Platform, featuring innovative stone management technologies, to be unveiled  EDAP's cutting edge High Intensity Focused Ultrasound (HIFU) and Extracorporeal Shockwave Lithotripsy (ESWL) technologies will

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Approved November 9 2015
Ablatherm-HIFU (High Intensity Focused Ultrasound)
Cancer - Low risk, localized prostate cancer

Latest News

  1. EDAP Issues Letter to Shareholders

    Recaps significant progress made in 2019 and previews expectations for accelerating global growth in 2020 LYON, France, January 9, 2020 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in

  2. EDAP Announces Publication of Focal One® Endometriosis Study in the Journal Ultrasound in Obstetrics & Gynecology

    Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis LYON, France, December 19, 2019 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced

  3. EDAP Announces First Focal One® HIFU treatments at Farrer Park Hospital in Singapore

    Farrer Park Hospital becomes the first hospital in Southeast Asia to implement Focal One®EDAP poised to expand HIFU in Southeast Asia LYON, France, November 26, 2019 -- EDAP TMS SA (NASDAQ:EDAP) ("the

  4. EDAP Reports 2019 Third Quarter and Nine Months Results

    67.8% growth in  HIFU revenue through the nine month period ended September 30 over the comparable period in 201848.2% Gross margin for the nine month period ended September 30 compared to 42.3% for the comparable period

  5. EDAP to Introduce New Endo-UP® Endourology Platform During the 2019 World Congress of Endourology

    New Endo-UP® Platform, featuring innovative stone management technologies, to be unveiled  EDAP's cutting edge High Intensity Focused Ultrasound (HIFU) and Extracorporeal Shockwave Lithotripsy (ESWL) technologies will

  6. EDAP TMS SA to Announce Third Quarter and Nine Months 2019 Financial Results on Wednesday, November 13, 2019

    Company to host conference call and webcast on Thursday, November 14, at 8:30 am EDT LYON, France, October 24, 2019 - EDAP TMS SA (NASDAQ:EDAP), the global leader in therapeutic ultrasound, today announced that it will

  7. EDAP Reports 2019 Second Quarter Results

    Third consecutive profitable quarter Positive reimbursement decision by the American Medical Association announced in June Significant improvement in gross profit margin from 41.3% in Q2 2018 to 50.7% in Q2 2019 Q2 HIFU